Program Goals

This program will inform urologists about the current methods for detection and treatment of non-muscle invasive bladder cancer. Didactic presentations followed by a question and answer session will provide important principles for the management of patients with non-muscle invasive bladder cancer.

Target Audience

Healthcare professionals involved in the treatment of bladder cancer.

• Physicians: Urologists (Board Certified, Board Eligible, Fellow and Residents), Uropathologists, Uro-oncologists
• Ancillary healthcare professionals: PAs, RNs, PhDs, research personnel, lab professionals

Educational Objectives

After completing this activity, the participant should be able to:

• Discuss the recommendations of the American Urological Association and the European Association of Urology for the treatment of non-muscle invasive bladder cancer, including adequate biopsy and adjuvant therapy.
• Describe statistical analyses that characterize the performance of urine-based diagnostic tests.
• Explain the performance characteristics of urine-based tests for the detection of bladder cancer.

Faculty

H. Barton Grossman, MD
W. A. “Tex” and Deborah Moncrief, Jr. Distinguished Chair in Urology
Professor and Deputy Chairman, Department of Urology
The University of Texas M. D. Anderson Cancer Center

J. Stephen Jones, MD
Chairman, Department of Regional Urology
Glickman Urological and Kidney Institute, Cleveland Clinic
Associate Professor of Surgery (Urology)
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Michael A. O’Donnell, MD
Professor, Department of Urology
Chief, Urologic Oncology
University of Iowa Hospitals and Clinics

Educational Program Agenda

• 05 minutes: Welcome & Introduction
• 50 minutes: Didactic Presentations
• 20 minutes Case Presentations
• 10 minutes: Evaluation & Post-Test
• 05 minutes: Conclusion

Disclosure of Conflicts of Interests

Instructors, planners, managers and other individuals who are in a position to control the content of this activity are required to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty Disclosures

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this P.A.C.E.^®activity:

Faculty Disclosure Summary

The American Society for Clinical Laboratory Science and Dane Garvin Ltd. adhere to established standards regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, are made known above.

Planners and Managers

The planners and managers of this educational activituy reported the following financial relationships, or relationships to products or devices they or their spouse/life partner have with the commercial sponsors of the activity:

Credit Designation - Lab Professional, P.A.C.E.^®

The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.^®) Program will provide 1.5 contact hour of credit.

How to Obtain P.A.C.E.^® Credit

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.5 contact hour of  P.A.C.E.^® approved continuing education. To receive credit, the course must be completed before October 1, 2012.

Participation in this activity should be completed in approximately 1.5 hour. Please follow these steps in order to receive P.A.C.E.^® credit for viewing the webcast:

• Read all of the information above.
• View the complete webcast program.
• Click on the link to apply for P.A.C.E.^® credit.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
• After successful completion of this process, you will be redirected to the ASCLS CE Organizer where you may create and print an official ASCLS P.A.C.E.^® certificate based on your attendance and completion of this ASCLS-sponsored P.A.C.E.^® approved learning activity.

Should you have any P.A.C.E.^® questions regarding this activity, please contact:

ASCLS P.A.C.E.^®
1861 International Drive, Suite 200
Tysons Corner, VA 22102
Ph: 571-748-3776
Fx: 571-354-7576
https://www.ascls.org/

Release and Expiration

Release Date: October 1, 2011
Expiration date: October 1, 2012

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Clincal Laboratory Science and Dane Garvin Ltd. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

Dane Garvin Ltd. protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Dane Garvin Ltd. will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Dane Garvin, Ltd. maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available online.

"Bladder Cancer: Diagnosis, Markers and Treatment"

System Requirements

To view this educational activity you will need a web browser with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.

Cosponsors

Cosponsored by:

Commercial Support Statement

    This activity supported by an educational grant from Abbott Molecular.

Copyright

Copyright © October 1, 2011 - October 1, 2012 by Dane Garvin, Ltd. All Rights Reserved. Permission for accreditation is granted to the American Society for Clinical Laboratory Science.